Francesca Spada shared a post on LinkedIn:
”Is it the time of precision oncology in NENs? Our speakers reply with:
- Amazing letture on the molecular landscape of NENs.
- A look to the future with the value of liquid biopsy.
- New amazing nuclear tracers incoming.
- Next step forward in systemic therapy.”
Source: Francesca Spada/LinkedIn
Francesca Spada, M.D., Ph.D. is a Medical Oncologist Assistant of Gastrointestinal Medical Oncology and Neuroendocrine Tumors Division at the European Institute of Oncology (IEO), Milan, Italy. She has carried out Multidisciplinary management of patients with neuroendocrine neoplasms, gastrointestinal and hepato-bilio-pancreatic cancers.